Introduction
Cell division ultimately depends on ubiquitin-mediated protein degradation. In eukaryotes, an inhibitor of sister chromatid separation, securin, and a mitotic exit inhibitor, the cyclin B-Cdk1 protein kinase, start to be degraded once all chromosomes have attached to the mitotic spindle in a bipolar fashion (reviewed in Pines, 2006) . Both securin and cyclin B are recognized by the APC/C ubiquitin ligase, which is activated by the Cdc20/slp1/fizzy protein (hereafter referred to as Cdc20) (reviewed in Peters, 2006) . Cdc20 binds and activates the APC/C in vitro (reviewed in Yu, 2007) , and Cdc20 mutants in budding and fission yeasts, C. elegans, Drosophila, and mice all arrest in mitosis, indicating that the protein is essential for progress through mitosis. In Drosophila, fizzy mutants arrest with high levels of both cyclin A and cyclin B (Sigrist et al., 1995) . A second APC/C activator, Cdh1/ste9/fizzy-related (hereafter referred to as Cdh1), is held in check by mitotic phosphorylation on Cdk consensus sites in early mitosis and replaces Cdc20 in late mitosis and G1 phase after cyclin-Cdk activity has declined (reviewed in Peters, 2006) .
During mitosis, any chromosomes improperly attached to the mitotic spindle activate the spindle assembly checkpoint, which prevents the APC/C from recognizing securin and cyclin B1, thereby blocking both sister chromatid separation and exit from mitosis (reviewed in Musacchio and Salmon, 2007) . Although the exact mechanism by which the spindle checkpoint acts on the APC/C is not yet clear, both genetic and biochemical evidence indicate that the checkpoint machinery principally targets Cdc20. The prevailing model is that improperly attached kinetochores catalyze the inactivation of Cdc20 by promoting its binding to checkpoint components such as Mad2, BubR1, and Bub3 (Fang et al., 1998; Sudakin et al., 2001; Tang et al., 2001) . However, although the spindle checkpoint prevents the Cdc20-dependent destruction of cyclin B and securin, it fails to inhibit the degradation of cyclin A (den Elzen and Pines, 2001; Geley et al., 2001) , in contrast to inactivating Drosophila Cdc20 genetically, which does prevent cyclin A destruction in mitosis (Dawson et al., 1995; Sigrist et al., 1995) .
Cyclin A-Cdk complexes regulate the initiation of mitosis and progression through prophase in mammalian cells (Furuno et al., 1999; Pagano et al., 1992) . Because cyclin A destruction is spindle-checkpoint independent, it starts as soon as the APC/C is activated in mitosis, which correlates with nuclear envelope breakdown (den Elzen and Pines, 2001; Geley et al., 2001 ). It is not clear whether cyclin A must be degraded before cyclin B and securin for proper progression through mitosis, although overexpressing cyclin A does prevent anaphase in human and Drosophila cells and, in some cases, prevents the formation of a stable metaphase plate (den Elzen and Pines, 2001; Sigrist et al., 1995) . Nevertheless, in all cells that have both an A-and a B-type cyclin, the A cyclin is always degraded first (den Elzen and Pines, 2001; Evans et al., 1983; Hunt et al., 1992; Sigrist et al., 1995) .
How cyclin A can be targeted for destruction when the spindle checkpoint is active is unknown. Cyclin A has an extended ''destruction box'' motif in its amino terminus that is necessary, but not sufficient, for degradation in prometaphase (Klotzbucher et al., 1996) . Moreover, mutations that prevent Cdk binding delay degradation until anaphase (den Elzen and Pines, 2001; Geley et al., 2001; Stewart et al., 1994) , and a mutation in Drosophila cyclin A that binds but does not activate Cdk1 is still degraded in vivo (Ramachandran et al., 2007) . One interpretation of these results is that cyclin A might bind to Cdc20 through an extended interaction motif composed of its amino terminus and its Cdk partner. Alternatively, Cdk binding may cause a conformational change in cyclin A to reveal its amino terminus. An extended interaction motif might increase the affinity for Cdc20 to allow cyclin A to compete for Cdc20 with the checkpoint complex. This could be encompassed in a model where a limited amount of Cdc20 could allow efficient cyclin A destruction in prometaphase, whereas cyclin B1 and securin could not be targeted until more Cdc20 became active upon silencing the checkpoint.
An attractive alternative model is that cyclin A could be bound and degraded by the APC/C entirely without Cdc20, and the requirement for fizzy in Drosophila could be indirect. This may be true for the Nek2A protein kinase that is also degraded in prometaphase. Nek2A has been reported to bind the APC/C independently of Cdc20, and this requires a methionine-arginine dipeptide at its C terminus (Hayes et al., 2006) , which resembles the isoleucine-arginine dipeptide at the C terminus of Cdc20 that helps to bind the APC/C (Kramer et al., 2000) , and might allow Nek2A to be ubiquitinated in the absence of Cdc20. However, it is unclear whether the APC/C can be active without any bound Cdc20, and cyclin A does not have an I/M-R dipeptide motif at its C terminus.
At mitosis, the mitotic cyclin-Cdks phosphorylate the APC/C to activate it (Patra and Dunphy, 1998; Rudner and Murray, 2000; Shteinberg and Hershko, 1999) . APC/C phosphorylation by the cyclin B-Cdk1 complex becomes more efficient if cyclin B-Cdk1 is bound to its small accessory subunit, Cks (Patra and Dunphy, 1998; Rudner and Murray, 2000) . The Cks proteins are conserved through evolution, bind to Cdk1 and Cdk2 in vitro, and have an anion binding site that is thought to facilitate binding to a previously phosphorylated Cdk consensus site (Bourne et al., 1996) . Thus, a cyclinCdk-Cks complex could remain bound to a substrate after phosphorylating one site and processively phosphorylate other nearby Cdk sites. The APC3 subunit is heavily phosphorylated on multiple Cdk consensus sites, and depleting Cks from Xenopus extracts markedly decreases APC3 phosphorylation in mitosis (Patra and Dunphy, 1998) .
Moreover, phosphorylated APC/C binds to a Cks affinity column (Sudakin et al., 1997) ,
and Cks mutants in a number of organisms arrest in mitosis with elevated levels of mitotic cyclins (Polinko and Strome, 2000; Rudner and Murray, 2000; Swan et al., 2005) .
In human cells, there are two Cks proteins, Cks1 and Cks2, which have both redundant and nonredundant roles in cell-cycle progression (Spruck et al., 2001; Spruck et al., 2003) . In mouse cells, Cks1 is required for the SCF-Skp2 ubiquitin ligase A-C1-Cerulean 68 hr after transfection with Cdc20 or GAPDH interference RNA oligos. After 2-3 hr, cells expressing cyclin A-Cerulean were followed through mitosis by DIC and fluorescence timelapse microscopy at 4 min intervals. The time on the image represents the time before and after nuclear envelope breakdown (NEBD). Fluorescence of single-cell images was measured (y axis) and plotted against the time before and after NEBD (x axis). Graphs showa GAPDH RNAi control cell as well as the cell in A. The Cdc20 RNAi cell shown is representative of 47 of 49 cells from six independent experiments. (B and C) Endogenous cyclin A levels are elevated in Cdc20 RNAi cells. HeLa cells were fixed 14 hr after release from thymidine/aphidicolin and 68 hr after transfection with GAPDH RNAi control (B) or Cdc20 RNAi (C) and stained for cyclin A (red in merge), Cdc20 (green in merge), and DNA (blue in merge). Projections of stacks of Z sections are shown. Cells are representative of 40 or more cells per phase for both (B) and (C).
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to target the p27Kip1 Cdk inhibitor for degradation in G1 phase (Ganoth et al., 2001; Spruck et al., 2001 ), whereas Cks2 is required for APC/C activity in meiosis I (Spruck et al., 2003) . Eliminating both Cks proteins is lethal . Here, we have investigated how cyclin A destruction is controlled and find that, contrary to our expectations, depleting Cdc20 affects cyclin A destruction as much as cyclin B1 destruction. Indeed, a significant proportion of cyclin A directly binds to Cdc20 in G2 phase and mitosis, and this complex contains little or no Mad2. Furthermore, depleting Cks1 and Cks2 stabilizes cyclin A independently of the effect on APC/C phosphorylation, and a Cdk mutant unable to bind to a Cks subunit does not allow cyclin A destruction in prometaphase. Thus, we propose that cyclin A is targeted to the APC/C by the Cks subunit of its Cdk partner, which promotes cyclin A destruction through the Cdc20 bound to cyclin A.
Results
Cdc20 levels are rate limiting for the degradation of cyclin A We set out to determine how cyclin A can be degraded independently of the spindle checkpoint but still depend genetically on Cdc20. To test the possibility that cyclin A Figure 1A and microinjected with 5 ng/ml of pCMX-cyclin B1-YFP. Cells expressing cyclin B1-YFP were assayed as in Figure  1A . Graphs show a GAPDH RNAi control cell (top) as well as the cell in A (bottom). The Cdc20 RNAi cell shown is representative of 37 cells from six independent experiments. (B and C) Endogenous cyclin B1 is degraded at the right time in Cdc20 RNAi cells. HeLa cells were fixed 14 hr after release from thymidine/ aphidicolin (mitotic peak) and 68 hr after transfection with GAPDH RNAi control (B) or Cdc20 RNAi (C) and stained for cyclin B1 (red), Cdc20 (green), and DNA (blue). Projections of z-stacks are shown. Cells shown are representative of more than 30 cells per phase.
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could be degraded with much lower levels of Cdc20 than required for cyclin B1 or securin destruction, we reduced the level of Cdc20 by siRNA. When we reduced Cdc20 levels by over 98% (oligo 14 in Figure S1 available online), this blocked cells in midmitosis and stabilized both cyclin A and cyclin B1 (data not shown), in agreement with the recent demonstration that Cdc20 is essential for anaphase and exit from mitosis (Li et al., 2007) . However, when we reduced Cdc20 levels by ~90% (oligos 7, 8, and 10 in Figure S1A ), this delayed but did not block cells in mitosis. We reasoned that this might uncover a rate-limiting role for Cdc20 and, therefore, carried out all further Cdc20 depletions with oligo 7 and oligo 8 in parallel experiments. All data shown are for oligo 8, and very similar results were obtained for oligo 7. Cdc20 siRNA cells took an average of at least 60 min to progress from NEBD to anaphase (n = 60), whereas control cells took an average of 30 min. Some cells depleted of Cdc20 took hours to progress through prometaphase and during this time were unable to form a stable metaphase plate, reminiscent of the effect of overexpressing cyclin A (den Elzen and Pines, 2001) . Therefore, we assayed cyclin A degradation by using a live-cell assay where the fluorescence level of a cyclin A-fluorescent protein is a readout of protein level. Using this assay, we, and others, had previously shown that cyclin A begins to be degraded immediately after nuclear envelope breakdown (NEBD) (den Elzen and Pines, 2001; Geley et al., 2001 ) ( Figure  S2 ). However, in cells depleted of Cdc20, cyclin A degradation was delayed; indeed, in ~33% of cells, it was stable for an extended period after NEBD ( Figure 1A and Figure  S2 ). Moreover, ectopically expressed cyclin A enhanced the phenotype of the Cdc20-depleted cells such that the majority of cells were still in mitosis by the end of the experiment (10 hr, Figure S3 ). In contrast, cyclin A destruction always began at NEBD regardless of its expression level (over a 10-fold range) in control cells ( Figure S2 ). These results indicated that Cdc20 became rate limiting for cyclin A destruction in Cdc20 siRNA cells. Consistent with this, when we measured the levels of endogenous cyclin A (in cells without ectopic cyclin A) by immunofluorescence, Cdc20-depleted cells had high levels of cyclin A in prometaphase and even metaphase cells still had significant amounts of cyclin A ( Figure 1C and Figures S1B-S1D ). By contrast, cyclin A levels in control cells were high in prophase, much lower in prometaphase, and lowest in metaphase, consistent with normal cyclin A destruction in prometaphase ( Figure 1B) .
We also assayed cyclin B1 and securin to determine whether their destruction was similarly affected by depleting Cdc20. Unlike cyclin A, both cyclin B1-YFP ( Figure 2A and Figure S4 ) and securin-YFP ( Figure S5 ) destruction began on cue once Cdc20-depleted cells reached metaphase. In some cells, cyclin B1 degradation was largely unaffected, but in others, it was degraded at a markedly slower rate and cells took longer to reach anaphase. However, unlike cyclin A, low levels of ectopic cyclin B1 did not block Cdc20-depleted cells in mitosis ( Figure S3 ). The levels of endogenous cyclin B1 declined at metaphase, and cyclin B1 was largely absent by anaphase both in control ( Figure 2B ) and Cdc20-depleted cells ( Figure 2C and Figure S6 ).
Cdc20 forms a complex with cyclin A before mitosis One explanation for why higher levels of cyclin A reduced its own rate of destruction in Cdc20-depleted cells was that Cdc20 might be a limiting recruitment factor for cyclin A, but not for cyclin B1. Consistent with this, the amino terminus of cyclin A binds to Cdc20 in a yeast two-hybrid assay (Ohtoshi et al., 2000) , whereas a tandem repeat of the amino terminus of cyclin B1 can bind to the APC/C in the absence of Cdc20 (Yamano et al., 2004) . Therefore, we assayed whether cyclin A bound to Cdc20 in vivo and found that a significant fraction of Cdc20 coimmunoprecipitated with cyclin A ( Figure 3A and Figure S7 ). In support for a role as a recruitment factor, Cdc20 associated with cyclin A in G2 phase, before the bulk of the APC/C was activated ( Figure 3A) . In contrast, cyclin B1 was not detected in complexes with Cdc20 before mitosis ( Figure 3A ; the asterisk indicates residual cyclin A signal). The interaction with Cdc20 correlated with the ability of cyclin A to be degraded because wild-type cyclin A and not a nondegradable mutant of cyclin A lacking its amino terminus bound most efficiently to Cdc20 ( Figure 3B ). When cyclin A was stabilized by blocking the proteasome with MG132, cyclin A-Cdc20 complexes clearly persisted into mitosis ( Figures 3C and 3D ). Moreover, in these cells, Mad2 was readily detectable in a complex with Cdc20 but almost completely absent from cyclin A-Cdc20 complexes ( Figures 3C and 3D ).
Cks proteins are required for cyclin A destruction
Because cyclin A was already bound to Cdc20 before cells entered mitosis, this might allow cyclin A to be degraded if it were recruited to the APC/C. Cyclin A forms a trimeric complex with its partner Cdk (Cdk1 or Cdk2) and a Cks1 or Cks2 protein. The crystal structure of the cyclin A-Cdk2-Cks complex showed that the Cks subunit created an enlarged substrate-binding site with an increased affinity for phosphoproteins (Bourne et al., 1996) , and Cks proteins bind strongly to the phosphorylated form of the APC/C (Sudakin et al., 1997) . Because timely destruction of cyclin A requires its interaction with a Cdk partner and coincides with a strong increase in APC/C phosphorylation, we considered the possibility that cyclin A-Cdk complexes might be recruited to the phospho-APC/C through its Cks subunit.
We first determined whether Cks proteins form complexes with cyclin-Cdks at the right time in the cell cycle to play a role in cyclin destruction. Cks1 and Cks2 levels were highest in G2 and M phase, declined slightly when cells exited mitosis, and were lowest in S phase ( Figure 4A ). Similar results were obtained in HeLa and RPE cells (data not shown). Cks1 and Cks2 complexes with cyclin A-Cdk2 (Figures 4B and 4C) and cyclin B1-Cdk1 ( Figure 4C ) were abundant prior to the start of cyclin destruction. Cks1-and Cks2-FP fusion proteins bound to cyclin A and cyclin B1 (data not shown) and localized to the mitotic spindle in prometaphase ( Figure 4D ). In G2 phase, Cks1-YFP was most clearly detected in the nucleus and the cytoplasm, and it further accumulated in the nucleus in late prophase, consistent with its interaction with both cyclin A and cyclin B1 ( Figure 4E ). In prometaphase, when cyclin A was degraded, Cks1-YFP not only localized to the mitotic spindle but also became slightly more cytoplasmic ( Figure 4E , compare panels 3, 4, and 5). It completely dispersed in early anaphase, when cyclin B1 had also been degraded ( Figure 4E ).
To determine whether Cks proteins were required for cyclin destruction, we reduced the levels of Cks1 and Cks2 by using shRNA vectors ( Figure 5A ) or pools of four different siRNA oligos (Figures 5B and 5C) . Both methods caused a reduction in Figure 3 . Complex formation between Cyclin A, Cdc20, and the APC/C. (A) In G2 phase, cyclin A, but not cyclin B1, binds to Cdc20 independently of the APC/C. G2 phase U2OS cells (~80% 4n, <10% mitotic) were lysed and APC4, cyclin A, Cdc20, and GFP (negative control) immunoprecipitated. Twenty percent of the whole-cell extracts are shown as input in theleft lanes. Cdc20 and cyclin A immunoprecipitates show that ~20% of the total amount of cyclin A was bound to Cdc20 (likely to be an underestimate because neither Cdc20 nor cyclin A was fully depleted from the extracts). The blot was reprobed for cyclin B1 (lower panel), revealing that cyclin B1 does not bind to the APC/C or Cdc20. The asterisks indicate the residual cyclin A signal. (B) Nondegradable cyclin A binds less efficiently to Cdc20. G2 phase U2OS cells expressing wildtype cyclin A-GFP, or a nondegradable mutant of cyclin A-GFP lacking its amino terminus (DN-cyclinA), were lysed, and anti-GFP immunoprecipitates were probed for Cdc20 and Cdk2. (C) Cyclin A binding to Cdc20 is sustained in mitosis. Cells were arrested in mitosis by nocodazole (left, lane 1), MG132 (lane 3), or nocodazole + MG132 (lane 4). In lane 2, nocodazole-arrested cells were collected by shake-off and released. Cells were lysed, and extracts were split and either blotted for cyclin A, Cdc20, Cdk2, or Mad2 (left panels) or used to immunoprecipitate Cdc20 or cyclin A and subsequently probed for Cdc20 (top panels, middle) or Mad2 (lower panels, right). (D) Mitotic cyclin A-Cdc20 complexes have very little Mad2. U2OS cells were released from thymidine, and 9 hr after release, both taxol (1 mM) and MG132 (5 mM) were added. Arrested cells were lysed, and Mad2, cyclin A, and GFP (negative control) were immunoprecipitated and probed for APC3, Cdc20, cyclin A, and Mad2. Cks fusion proteins localize to mitotic structures. U2OS cells were transfected with pCks1-EYFP, pCks1 EYFP, or pEYFP and followed by time-lapse microscopy 40 hr later. In prometaphase, the Cks1 and Cks2 signals specifically localize to the mitotic spindle and the poles. (E) Cks1-EYFP localizes to centrosomes, spindle poles, and potentially to kinetochores in early mitosis. U2OS cells were cotransfected with pCks1-EYFP and Cks2 RNAi oligos and followed by time-lapse microscopy 40 hr later. In G2 phase (first panel), Cks1 localized to the cytoplasm, nucleus, and centrosomes (weakly visible on top of the nucleus). In prophase, Cks1 further accumulated in the nucleus (second panel). From prometaphase to metaphase, Cks1 localized to the spindle and progressively to the cytoplasm (third to sixth panels), and it was entirely cytoplasmic in anaphase and telophase (seventh and eighth panels). In G1, Cks1 re-entered the nuclei. . Mitotic cells were collected by shake-off in nocodazole 16 hr after release from a thymidine block (>95% of these cells were mitotic as judged by MPM2 staining). Extracts were probed for APC3, APC2, Cdc20, cyclin A, Cdk2, p27, Cks1, and Cks2. (C) Cks proteins and the APC/C are both necessary for cyclin A destruction. Cells were cotransfected with 100 pmol of four pooled Cks RNAi oligos, or oligos directed against the APC/C cullin-like subunit APC2 (left lanes), or scrambled control RNAi oligo (middle lanes), or oligos against both Cks1 and Cks2 (right lane). Mitotic cells were collected by shake-off in nocodazole 16 hr after release from a thymidine block (>90% of these cells were mitotic as judged by MPM2 staining). Extracts were probed for APC3, APC2, cyclin A, and Cks1/2. (D) Cks1 and Cks2 codepletion delays anaphase. Cells transfected as in (B) with a pool of Cdc20 RNAi oligos (also see Figure S1 ), or a mixture of pooled Cks1 and Cks2 RNAi oligos, or control RNAi oligos were assayed by time-lapse microscopy 48 hr after transfection. At this time, Cdc20 depletion was incomplete, resulting in a mitotic delay equivalent to the delay observed after treatment with Cks1 and Cks2 (upper graph, y axis: time between nuclear envelope breakdown and onset of anaphase, as determined by DIC. Error bar, standard deviation). Typically, 10%-20% of the cells treated with Cks1 and Cks2 RNAi did not show a delay (lower panel; representative experiment of three experiments). Immunofluorescence analyses revealed that a similar percentage of cells were still positive for Cks (data not shown), strongly indicating that partial depletion of Cks proteins does not result in a mitotic phenotype. Whole-cell extracts from G2 phase and mitotic cells (collected by shake-off) in which Cdk1 was replaced with P242L-Cdk1-YFP or wild-type Cdk1-YFP as described in (B) were probed for APC3 to detect APC3 phosphorylation, GFP to detect Cdk1-YFP expression levels, cyclin A, and Cdc20. (E) P242L-Cdk1 partially stabilizes cyclin A-CFP. G2 phase U2OS cells, cotransfected as in (B), were microinjected with 10 ng/ml of pCDNA3-myc-cyclin A-ECFP 48 hr after transfection and followed through mitosis by time-lapse microscopy at 3 min intervals. The average percentage of the cyclin A fluorescence was measured, corrected for Cdk1-EYFP signal, and plotted against the time after NEBD for cells in which Cdk1 depletion was rescued by Cdk1-YFP (gray circles) or Cdk1-P242L-YFP (blue triangles). Graph shows the average of 7 cells (Cdk1) and 11 cells (Cdk1-P242L) in three independent experiments.
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the phosphorylation of the APC/C subunit APC3 in nocodazole-arrested cells ( Figures  5A-5C ). Although G2 phase cells depleted of Cks1 and Cks2 entered mitosis with fairly normal kinetics, most cells were subsequently delayed in mitosis without forming a stable metaphase plate, in a similar manner to cells partially depleted of Cdc20 where cyclin A destruction was defective ( Figure 5D and Figure S9 ). In agreement with this, cyclin A was stabilized in mitotic cells depleted of both Cks1 and 2 ( Figure  5B ) to a similar extent as in cells depleted of the APC/C subunit APC2 ( Figure 5C and Figure S9 ). We observed no changes in the level of Cdc20 upon depletion of the Cks proteins (see Figure 5B ). Reducing only Cks1 or Cks2 revealed no effect on APC/C phosphorylation or cyclin A destruction, although depletion of Cks1 alone was sufficient to stabilize p27 ( Figure 5B) .
A non-Cks binding mutant of Cdk1 interferes with APC/C phosphorylation Our results were consistent with a model in which Cks proteins are responsible for the Cdk dependency of cyclin A degradation. However, Cks depletion also reduced the phosphorylation of the APC/C; therefore, cyclin A could have been stabilized by the consequent reduction in APC/C activity. To discriminate between a direct and an indirect role for the Cks proteins in cyclin A destruction, we first constructed a mutant of human Cdk1, P242L, that could not bind Cks proteins (analogous to the Cdc28-1N mutation identified in budding yeast Cdk1). This mutant failed to interact with the Cks proteins in vitro (data not shown) and in vivo ( Figure 6A ). We removed endogenous Cdk1 by shRNA and replaced it with an RNAi-resistant YFP-tagged version of either wild-type Cdk1 or the P242L mutant ( Figure 6B ) and found that cells in which endogenous Cdk1 was replaced with Cdk1-P242L also delayed in mitosis. Whereas wild-type Cdk1-YFP fully complemented the phenotypes of cells depleted of Cdk1 and restored maximal mitotic APC3 phosphorylation ( Figure 6D ), APC3 was only partially phosphorylated in Cdk1-P242L mitotic cells ( Figure 6D ). This was confirmed by staining Cdk1-P242L cells with an antibody that specifically detects APC3 phosphorylated on Thr446 ( Figure 6C ). Cells also delayed in prometaphase in a similar fashion to cells depleted of Cks1 and 2. Cyclin A was still degraded in Cdk1-P242L-expressing cells treated with nocodazole ( Figure 6D ), indicating that reduced APC/C phosphorylation was insufficient to explain the more robust stabilization of endogenous cyclin A we observed after depleting the Cks proteins ( Figures 5B and 5C ). In contrast, cyclin A destruction was strongly impaired in Cdk1-P242L cells expressing additional cyclin A-CFP ( Figure 6E ). In these cells, Cdk1-P242-YFP localization in G2 phase changed from predominantly cytoplasmic to predominantly nuclear, consistent with it binding to cyclin A. This indicated that a significant amount of the ectopically expressed cyclin A bound to Cdk1-P242L, apparently rendering the ectopic cyclin A more stable in mitosis. This was consistent with a direct role for Cks proteins in the destruction of Cdk-bound cyclin A. To test this hypothesis, we needed an assay to monitor specifically cyclin A in a complex with the non-Cks binding Cdk mutant in a cell with normal phosphorylation Wild-type and non-Cks binding cyclin A-Cdk2 BiFC complexes interact with Cdc20 and leave APC/C phosphorylation unchanged. U2OS cells were cotransfected with 1 µg of pCS2-cyclin A-Venus-N and 0.5 µg of puromycin resistance vector, with either 1 µg of pCS2-Cdk2-Venus-C or pCS2-Cdk2-P241L-Venus-C. G2 and M phase Puromycin-treated cells were lysed 12 hr after release from a thymidine block and probed for APC3 (top panel) or immunoprecipitated with anti-GFP (lower panels). Immunoprecipitates were split and either probed for cyclin A (second panel) and Cdc20 (third panel) or assayed for histone H1 kinase activity (bottom panel). (B) Cyclin A-Cdk2 BiFC complexes are degraded at the correct time. G2 phase U2OS cells were microinjected with 10 ng/ml of both pCS2-Cdk2-Venus-N and pCS2-cyclin A-Venus-C and followed through mitosis by DIC and fluorescence time-lapse microscopy at 3 min intervals (left panels). The time on the images is in hrs:min. T = 6.05 hr represents nuclear envelope breakdown (NEBD); cyclin A destruction starts 5 min later. The cell divides after a delay identical to the delay observed after ectopic expression of fluorescent WT-cyclin A at physiological levels (den Elzen and Pines, 2001) . Graph, cyclin A-Cdk2 fluorescence was measured and plotted against the time before and after NEBD. Graph shows cell in B. Cell is representative of 16 of 21 cells from three independent experiments. (C) Cyclin A destruction requires binding to Cks. G2 phase U2OS cells were microinjected with 10 ng/ml of both non-Cks binding pCS2-Cdk2-P241LVenus-N and pCS2-cyclin A-Venus-C and followed through mitosis by DIC and fluorescence time-lapse microscopy at 3 min intervals (top panels). The time on the images is in hrs:min. T = 0.21 represents nuclear envelope breakdown (NEBD); fluorescence levels increase in mitosis due to residual translation, identical to that observed after expression of nondegradable cyclin A-CFP (den Elzen and Pines, 2001) . Graph, the total fluorescence minus background of single-cell images was measured and plotted against the time before and after NEBD. Graph shows cell in (C). Cell is representative of 11 of 28 cells from three independent experiments. The remaining 17 cells revealed slow destruction of cyclin A that did not start on time, very similar to the graph of cyclin A destruction in cells depleted of Cdc20 shown in Figure 1. A B C of the APC/C. To do this we turned to bimolecular fluorescence complementation (BiFC) (Hu et al., 2002) .
Cyclin A bound to Cdk2-P241L cannot be degraded in mitotic cells BiFC uses the remarkable property of the fluorescent proteins that two separate halves of the protein can still fluoresce when brought close enough to each other (Hu et al., 2002) . Therefore, we tagged cyclin A with the amino-terminal half of Venus (a form of YFP), tagged Cdk2-either the wild-type or a P241L mutant (equivalent to P242L Cdk1)-with the C-terminal half of Venus, and then introduced them into cells at low levels. This allowed us to follow cyclin A-Cdk2 complexes as APC/C substrates in otherwise unperturbed cells. Note that we observed no differences in the localization, activity, or degradation of cyclin A bound to Cdk1 compared with Cdk2 (Koop, 2007) . BiFC complexes between cyclin A and the wild-type or the Cdk2-P241L mutant developed fluorescence, were able to bind Cdc20 in G2 phase, and had similar associated histone H1 kinase activities ( Figure 7A ). Both complexes were primarily nuclear in interphase, like the endogenous cyclin A-Cdk2 complex, and cells expressing either cyclin A-Cdk2 or cyclin A-Cdk2-P241L BiFC showed similar levels of APC3 phosphorylation in mitosis ( Figure 7A ). When we analyzed the degradation of the cyclin A-Cdk2 BiFC complex by time-lapse fluorescence microscopy, we found that the cyclin A began to be degraded just after nuclear envelope breakdown, at the same time as endogenous cyclin A ( Figure 7B ). However, cyclin A in the complex with Cdk2-P241L was not degraded at NEBD: it remained stable for several hours ( Figure  7C ). Thus, cyclin A must be bound to a Cdk capable of binding to a Cks protein to be degraded in prometaphase.
Discussion
In this paper, we have shown that, by forming a complex with Cdc20 and a Cks protein, cyclin A can be degraded independently of the spindle checkpoint. Moreover, depleting Cdc20 uncovers a rate-limiting role in cyclin A degradation, despite Cdc20 being the principle target of the spindle checkpoint. Thus, our results exclude the models that cyclin A can be degraded independently of the spindle checkpoint because it is intrinsically a much better substrate of APC/C-Cdc20 or that it does not require Cdc20 at all. cyclin A forms a complex with Cdc20 in interphase and during early mitosis, and the stability of cyclin A increases in proportion to its level in Cdc20-depleted cells, indicating that cyclin A titrates out Cdc20. In contrast, cyclin B1 is not found associated with Cdc20 until cells have entered mitosis. This difference in the time of association with Cdc20 is likely to be part of the explanation for how the timing of cyclin A and B1 differ. Additionally, even high levels of cyclin B1 and securin can be degraded at the right time in metaphase, and often with apparently normal kinetics, in cells with only 10% of the normal level of Cdc20, which may indicate that Cdc20 has a more stoichiometric role in cyclin A ubiquitination than in cyclin B1 and securing ubiquitination. Furthermore, the cyclin A-Cdk complex must bind a Cks protein to be degraded in prometaphase, and this is not related to the effect of Cks in promoting APC/C phosphorylation. We propose that the cyclin A-Cdk-Cks complex is recruited to the phosphorylated APC/C by its Cks protein and that its attached Cdc20 protein causes cyclin A to be degraded regardless of whether the spindle checkpoint is active or not.
Our results show that APC/C phosphorylation is important to recruit APC/C substrates, and it will be important to determine whether other APC/C substrates also directly bind to the APC/C. Whether this is sufficient to trigger their degradation could then depend on whether they can bind directly to an APC/C activator or if the activator has to bind separately to the APC/C.
Our results show that cyclin A is not a better APC/C substrate than cyclin B1 or securin and question the recent proposal from in vitro ubiquitination assays that the order in which APC/C substrates are recognized is primarily conferred by the intrinsic processivity of their ubiquitination (Rape et al., 2006) . We have tested the requirement for Cks in in vitro ubiquitination reactions with purified APC/C complexes but find that cyclin A can be ubiquitinated in the absence of either a Cdk partner or a Cks, indicating that these reactions do not recapitulate in vivo conditions (R.W., unpublished data; J.
Nilsson and J.P., unpublished data).
Our results reveal some unexpected insights into how the APC/C is regulated by the spindle checkpoint. Current models posit that Cdc20 is sequestered or inactivated by Mad2 or the mitotic checkpoint complex (reviewed in Musacchio and Salmon, 2007) , and our results require that this must be very efficient because even 10% of the normal level of Cdc20 can be sufficient for wild-type rates of cyclin B1 and securin degradation. Moreover, our data indicate that a proportion of Cdc20 must either be protected from inactivation, perhaps by being bound to cyclin A, or capable of mediating cyclin A destruction even after ''inactivation'' by Mad2/MCC. Mad2 does not coimmunoprecipitate with cyclin A; therefore, it is possible that binding to cyclin A prevents Cdc20 from binding to Mad2 (see for instance Figure 3 ). Although we were surprised to find that we had to deplete Cdc20 by more than 90% to affect cyclin B1 destruction, we find that we also need to deplete subunits of the APC/C to the same or a greater extent to have a measurable effect on APC/C activity in mitosis (D. Izawa and J.P., unpublished data; W.v.Z., and R.W., unpublished data). Thus, we are left to conclude that the cell contains a large excess of APC/C and Cdc20 over its minimum requirements for mitosis.
Potentially, Cks proteins also have a role to play in the destruction of the B-type cyclins. However, in contrast to cyclin A, the amino terminus of cyclin B1 alone starts to be degraded at the same time as wild-type cyclin B1 in mitosis (Clute and Pines, 1999) . Moreover, a tandem repeat of the amino terminus of cyclin B can bind to the phosphorylated APC/C in the absence of Cdc20 (Yamano et al., 2004) . Nevertheless, the mitotic phenotype of cells in which Cdk1 has been replaced by a non-Cks binding mutant cannot be fully explained by a delay in the destruction of cyclin A (W.v.Z. and R.W., unpublished data). We are currently further investigating the potential roles of the Cks proteins and APC/C phosphorylation in cyclin B1 and securin destruction. Mice lacking either Cks1 or Cks2 are viable, whereas knocking out both genes is lethal, pointing to a crucial, redundant role for the mammalian Cks proteins Spruck et al., 2003) . This role of the Cks proteins might be their requirement for cyclin destruction and could conceivably be relevant to their correlation with tumorigenesis. Cks1 and Cks2 mRNAs are overexpressed in a very high percentage of tumors (Keller et al., 2007; Shapira et al., 2005) , and although Cks1 has been linked with the regulation of p27Kip1 levels through its association with the SCF-Skp2 ubiquitin ligase, Cks2 does not have a role in this. Lastly, we find that slowing down cyclin A destruction prolongs the length of prometaphase and may delay the start of cyclin B1 and securin destruction. This may simply be a consequence of its effect on chromosome congression such that the chromosomes are not properly attached to microtubules, and thus, the spindle assembly checkpoint is not satisfied. However, we find that chromosomes continually congress and then move away from the metaphase plate, indicating that they are probably attached to both poles, and we have previously shown that Mad2 is not bound to kinetochores in cells overexpressing cyclin A (den Elzen and Pines, 2001 ). Thus, persistent cyclin A may affect the inactivation of the spindle checkpoint or the ability of APC/C-Cdc20 to recognize cyclin B1 and securin. These issues are currently being addressed.
Materials and methods
Plasmids and RNAi. Human cyclin A2, deltaN-cyclin A2, cyclin B1, ecuring, and Cdk1 were tagged at their C termini with the indicated spectral variants of GFP, using the pCMX or pCDNA3 vectors as previously described (den Elzen and Pines, 2001; Hagting et al., 2002; . Cks1 and Cks2 cDNA were amplified from a human cDNA library, cloned into pE-YFP-N1, and sequence verified. For the BiFC experiments, the cDNAs coding for human Cdk2 or human cyclin A2 were inserted in a pCS2+ vector encoding, respectively, either amino acids 1-145 or 146-237 of the Venus protein. Short-hairpin RNAi encoding vectors were generated in pSuper . The hairpins targeting human Cks1 and Cks2 cDNA spanned nucleotides 105-124 and 104-123, respectively. To deplete human Cdc20, we used annealed synthetic RNAi oligos spanning ORF nucleotides 156-174 (oligo 10), 486-504 (oligo 7), 484-504 (oligo 14), and 1128-1147 (oligo 8) from Dharmacon. For the experiment in Figure 5 , annealed siRNA pools to target APC2, Cdc20, Cks1, and Cks2 were purchased from Dharmacon as ON-TARGET-plus SMART pools.
Cell Culture, Synchronization, and Transfection. Cells were cultured and synchronized as previously described . Detailed descriptions are included in the Supplemental Experimental Procedures.
Immunoprecipitations and Western Blots. Approximately 23 106 cells were lysed in ELB+ (150mMNaCl, 50mM HEPES [pH 7.5], 5 mM EDTA, 0.3% NP-40, 10 mM β-glycerophosphate, 6% glycerol, 5mM NaF, 1mM Na2VO3, and Roche protease inhibitor cocktail). Lysates were cleared by centrifugation (13,000 x g, 8 min, 4˚C). Protein levels were equalized by using Bradford analysis. For immunoprecipitations, 2 mg antibodies were precoupled for 4-12 hr to 20 ml of protein G Sepharose (Amersham Biosciences) and washed with ELB+. Precoupled beads and lysates were incubated 4-12 hr at 4˚C and washed four times with 1.2 ml of ice-cold ELB+. All remaining buffer was then removed, and beads were resuspended in 50 ml sample buffer; 25 ml was separated on SDS-PAGE and blotted.
Antibodies. A list of the specific antibodies used is provided in Supplemental Experimental Procedures.
Immunofluorescence. Cells were seeded onto 22 mm coverslips 24 hr before addition of thymidine at 30% confluency. Fourteen hours after release from aphidicolin (mitotic peak), cells were washed once in PBS before fixation and processed as previously described . Deconvolved total projection 16 bit images were generated by using a DeltaVision microscope equipped with a 60x, 1.40 NA Olympus objective. Images were processed by linear scaling in Adobe Photoshop. Confocal imaging parameters for Figure 6 and Figure S8 are described in Supplemental Experimental Procedures.
Time-Lapse Fluorescence Microscopy and Microinjections. U2OS cells or HeLa cells were followed by time-lapse fluorescence microscopy as previously described . For those experiments used for quantitative analyses, all parameters were fixed within the indicated series of experiments. Timelapse images were processed by using Image J software (http://rsb.info.nih.gov/ij/ index.html), Slidebook 4.0 for OS X (Intelligent Imaging Innovations), or Metamorph 6.7 for Windows XP. A region was drawn around the edge of the entire cell (for the background, a region was drawn near the cell), the mean pixel intensity was calculated, and the total cell fluorescence was determined by [(Mean cell fluorescence) -(mean background fluorescence)] x cell area. Polinko, E.S., and Strome, S. (2000) . Depletion of a Cks homolog in C. elegans embryos uncovers a postmetaphase role in both meiosis and mitosis. Curr. Biol. 10, 1471 -1474 . Ramachandran, V., Matzkies, M., Dienemann, A., and Sprenger, F. (2007 . Cyclin A degradation employs preferentially used lysines and a cyclin box function other than Cdk1 binding. Cell Cycle 6, 171-181.
Rape, M., Reddy, S.K., and Kirschner, M.W. (2006) . The processivity of multiubiquitination by the APC determines the order of substrate degradation. Cell 124, [89] [90] [91] [92] [93] [94] [95] [96] [97] [98] [99] [100] [101] [102] [103] scanning modes. Using the emission prisms, 60% of the specific emission spectra of the used fluorophores were covered (Cdk1-EYFP, PMT1; Alexa568-APC3, PMT2; and CREST, PMT3). Scanning was at settings when no YFP signal was detected by PMT2, and no 568 signal by PMT1. Some weak and uniform background stain of CREST into the 568-PMT2 channel was unavoidable, but was similar in all cells, whereas phospho-APC3 staining was specific for mitotic cells (also see .
Antibodies. Rabbit anti-Cdc20 (Santa Cruz, H-175), mouse anti-Cdc20 (Santa Cruz, E-7), rabbit anti-fluorescent protein (Reits et al., 1997) , goat anti-APC6 (Santa Cruz, K-16), rabbit anti-Cyclin A (Santa Cruz, H-432) and mouse anti-Cyclin A (Abcam, clone 10.2), mouse anti-APC3 (Transduction Labs), goat anti-APC4 (Santa Cruz, C-18), rabbit anti-APC2 (kind gift of Hongtao Yu, Texas), goat anti-Actin (Santa Cruz), mouse antiCyclin B1 (GNS1, BD Biosciences), rabbit anti-Cks1 (generated by immunising rabbits with a C-terminal CLLFRRPLPKKPKK peptide of human Cks1, and affinity purifying Cks1 antisera on Cks1-coupled Sepharose beads), mouse anti-Cks2 (Zymed), rabbit anti-Cks1 and 2 (Abcam), mouse anti-Cdc20 (Santa Cruz, E7), rabbit anti-Mad2 (Bethyl, 300-301), mouse-anti Mad2 (MBL 2G9), mouse anti-Cdk1 (BD Transduction Laboratories 610037), mouse anti-p27 (BD Transduction Laboratories 610241), rabbit anti-Cdk2 (Santa Cruz, M-2), antiHsp70 monoclonal antibody H-5147, (Sigma). Rabbit anti-phospho-APC3-Ser447 (a kind gift of Franz Herzog and Jan Michael Peters, IMP, Vienna). PO-conjugated secondary antibodies used for Western blot were from DAKO. Blots were processed and developed as described (Lens et al., 2003) . The indicated bands were all specific as tested by RNA interference.
Synchronisations. HeLa or U2OS cells were cultured in Advanced DMEM (Invitrogen or Gibco) supplemented with 8% foetal bovine serum, glutamax-I (200 μM), penicillin (100 U/ml) and streptomycin (100 μg/ml). Cells were plated on glass bottom dishes (Willco Wells) or 9 cm Falcon dishes 16-24 hrs prior to synchronisation. HeLa cells were synchronised using a thymidine-aphodicolin block as described and U2OS cells with a double thymidine block. To obtain G2 phase cells and mitosis-enriched cultures, cells were incubated for the indicated times after release from a G1/S phase block. To arrest cells in mitosis, nocodazole (250 ng/ ml final concentration) was added 9 hrs after release from the G1/S phase block for 3-12 hrs. Cells were released from nocodazole by gentle mitotic shake-off . To obtain spindle checkpoint-inactivated mitotic cells, the mitotic cells were released from a nocodazole arrest in the presence of 5 μM MG132. Alternatively, mitotic cells were collected in the presence of MG132, 15 hrs after release from a thymidine block. For the experiment in Figure 3D , cells were released from thymidine, and taxol (1 μM) plus MG132 (5 μM) were added 9 hours after release. The effectiveness of synchronisation protocols was routinely checked by flow cytometry. An example is shown in Figure 4A . For time-lapse experiments, cells on Willco Wells dishes were transfected using 100 nmol of siRNA, 1 μg of pSuper vector, or 1 μg of pSuper vector plus 0.1 μg of expression plasmids as indicated. U2OS cells were transfected on 9 cm Falcon culture dishes, using either 600 pmol siRNA or cotransfected with a total 9 μgram of pSupershRNA, with 1 μgram of pBabe-puro by a calcium phosphate transfection protocol and selected with puromycin, as described . Specific downregulation was assayed by immunoblotting. Cyclin A-Cdk2-BiFC in vitro kinase assays were performed on anti-GFP immunoprecipitates, and processed as previously described . Figure S2 . Cyclin A degradation is delayed in Cdc20-depleted cells. G2 phase HeLa cells were micro-injected (10 hrs after release from thymidine/ aphidicolin and 68 hrs after transfection with control or Cdc20 RNAi) with 5 ng/ ml of pCDNA3-myc-Cyclin A-C1-Venus. Cells expressing the fluorescent proteins were followed through mitosis by DIC and fluorescence microscopy, imaged every 3 minutes and the fluorescence minus background measured and plotted over time. Plots of 9 cells out of 24 in 3 independent experiments are shown. Figure S2 . Cyclin A degradation is delayed in Cdc20-depleted cells G2 phase HeLa cells were micro-injected (10 hrs after release from thymidine/aphidicolin and 68 hrs after transfection with control or Cdc20 RNAi) with 5 ng/ml of pCDNA3-myc-Cyclin A-C1-Venus. Cells expressing the fluorescent proteins were followed through mitosis by DIC and fluorescence microscopy, imaged Figure S3 . Ectopic Cyclin A aggravates the mitotic delay of Cdc20 RNAi cells. G2 phase HeLa cells were micro-injected (10 hrs after release from thymidine/aphidicolin and 68 hrs after transfection with control or Cdc20 RNAi) with 10 ng/ml of pCDNA3-myc-Cyclin A-C1-Cerulean, or 3 ng/ml pVenus-N1-Securin, or 5 ng/ml of pCMX-Cyclin B1-YFP. Cells expressing the fluorescent proteins were followed through mitosis by DIC and fluorescence microscopy. Time between NEBD and Anaphase was measured for each cell and plotted as a percentage of the total. Figure S4 . Cyclin B1 degradation begins on time in Cdc20-depleted cells G2 phase HeLa cells were micro-injected (10 hrs after release from thymidine/aphidicolin and 68 hrs after transfection with control or Cdc20 RNAi) with 5 ng/ml of pCDNA3-myc-Cyclin B1-Venus. Cells expressing the fluorescent proteins were followed through mitosis by DIC and fluorescence microscopy, imaged every 3 minutes and the fluorescence minus background measured and plotted over time.
Plots of 5 cells out of 10 in 3 independent experiments are shown Figure S4 . Cyclin B1 degradation begins on time in Cdc20-depleted cells. G2 phase HeLa cells were micro-injected (10 hrs after release from thymidine/ aphidicolin and 68 hrs after transfection with control or Cdc20 RNAi) with 5 ng/ ml of pCDNA3-myc-Cyclin B1-Venus. Cells expressing the fluorescent proteins were followed through mitosis by DIC and fluorescence microscopy, imaged every 3 minutes and the fluorescence minus background measured and plotted over time. Plots of 5 cells out of 10 in 3 independent experiments are shown. G2 phase HeLa cells were micro-injected (10 hrs after release from thymidine/aphidicolin and 68 hrs after transfection with Cdc20 RNAi) with 3 ng/ml pVenus-N1-Securin. Cells expressing Securin-Venus were followed through mitosis by DIC and fluorescence microscopy and images taken every 3 minutes. Graph: the Figure S5 . Securin destruction is normal in Cdc20 RNAi cells.
G2 phase HeLa cells were micro-injected (10 hrs after release from thymidine/aphidicolin and 68 hrs after transfection with Cdc20 RNAi) with 3 ng/ml pVenus-N1-Securin. Cells expressing Securin-Venus were followed through mitosis by DIC and fluorescence microscopy and images taken every 3 minutes. Graph: the degradation of Securin-Venus was analysed by measuring the total fluorescence Figure S5 . Securin destruction is normal in Cdc20 RNAi cells. G2 phase HeLa cells were micro-injected (10 hrs after release from thymidine/ aphidicolin and 68 hrs after transfection with Cdc20 RNAi) with 3 ng/ ml pVenus-N1-Securin. Cells expressing Securin-Venus were followed through mitosis by DIC and fluorescence microscopy and images taken every 3 minutes. Graph: the degradation of Securin-Venus was analysed by measuring the total fluorescence minus background of the cell and plotted against the time before and after NEBD. Graph represents the degradation of the cell shown in A. The cell shown is representative of 13 cells from 3 independent experiments. Note that this cell displays a cut phenotype. Scalebar = 10 μm. Figure S7 . Complex formation between Cyclin A, Cdc20 and the APC/C in S and G2 phase cells. Cdc20 binds to Cyclin A, but not to Cyclin B1 or the APC/C, in S or G2 phase. Cdc20, APC6, and Cyclin A were immunoprecipitated from S phase and G2 phase U2OS cells and probed for Cdc20, Cyclin A, APC3 and APC4 (right panels). Protein levels in whole cell extracts (WCE) are shown in the left panels. Comparing bands of similar intensity on different exposures indicated that more than 20% of the total amount of Cyclin A was bound to Cdc20 in G2 phase. This is likely to be an underestimate because Cdc20 was not fully depleted from the extracts. We found the amount of Cdc20 bound to APC6 was reproducibly lower compared to the amount bound to APC4, shown in Figure 3A . Figure S8 . Endogenous Cks1 partially colocalizes with Cyclin A in interphase and mitosis. U2OS cells were fixed 14 hrs after release from a thymidine/ aphidicolin block (mitotic peak) and stained for Cks1 (green), Cyclin A (red), and DNA (blue). Projections of z-stacks are shown. Please note that Cks1 images are average projections of 15 z-planes. This is because a significant fraction of Cks1 is cytoplasmic, which becomes dominant on maximal intensity projections. Cells shown are representative of more than 10 cells per phase. 
